Q2 2026 saw 20% revenue growth, strong European performance, and strategic milestones like UK MoD supplier approval and new product launches. U.S. order delays impacted intake but are expected to recover in H2. Margins remained solid despite a temporary gross margin dip.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.